Wuxi Sta, A Subsidiary Of Wuxi Apptec, Has Announced A New Parenteral Formulation Manufacturing Line Has Started Operation At The Drug Product Site In Wuxi City, China. It Is The Second Line Opened This Year For Parenteral Drug Product Clinical And Commercial Manufacturing, With An Annual Capacity Of 10 Million Units. This Expansion Demonstrates The Company
